Tagged with CIS

Pharma Juan Fransisco Millán Sobaranes of Cetifarma, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discussed the agency’s major milestones and its main priorities for ensuring transparency, notably with regards to patient groups, healthcare practitioners, and clinical trials.   You were part of the initial team…

Pharma  Country manager AbdelAziz Shaheen discusses Pfizer’s current and recent investments in Egypt, which include significant contributions to the continuous education of Egyptian pharmacists and health care professionals. With 54 years history in Egypt, expanding manufacturing operations, and ambitions to see Egypt to become a production hub for Africa, Pfizer Egypt is…

pharma Francisco García was appointed as the executive director for the Puerto Rico Manufacturers Association (PRMA) in August 2015. He stresses the importance of developing Puerto Rico’s entrepreneurial talent and startup clusters as his main initiatives. As you have recently taken over as executive director of PRMA, could you outline the…

Francisco Arteaga-Martínez Francisco Arteaga-Martínez founded Caribbean Project Management (CPM) in 1991. Since then, the company has expanded considerably, with a presence now in Florida and Panama as a leading Puerto Rican construction management provider. He discusses the history, growth and key assets of the company. What were your intentions behind starting CPM?…

pharma The Director of the CNCR and the person in charge of the industrial sector, talk about the fragmented nature of French clinical research funding, why when it comes to boosting France’s attractiveness as a clinical research destination, funding is the number one issue for hospitals and reveals how the number…

Monash University Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region and explains the factors that will make the university a pharmaceutical leader.   There is a lot of competition in…

Afidro When we interviewed you in 2010, you mentioned that “while Colombia has had a solid transformation of the health system in a short time, being a model of success for Latin America, with 93% coverage of the population, it is time for the pharmaceutical industry to become a true player.…

Business & Decision Life Sciences Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business unit dedicated to the life sciences industry needed to be created back in 2007? Founded in 1992, Business & Decisions…

Dream CIS South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea’s clinical trial industry today? The quality of Korean medical service is already top notch; it is truly world class. However, the environment here has been…

Johnson & Johnson Russia & CIS In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they are older, to Acuvue contact lenses. What image does this company have in Russia? How is it positioned and how…

GSK Pharma CIS GSK CEO Andrew Witty has said that GSK must move away from selling “white pills in Western markets” in order to offset widespread generic erosion. This means diversifying the company’s portfolio into novel areas and putting greater emphasis on emerging markets. How is the Russian affiliate contributing to the realization…

NAARI AG Russia/CIS Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and reducing the nation’s reliance on imported pharmaceutical products. How do you believe the game has changed for foreign companies looking to play in Russia? Firstly, it is necessary to specify the…